Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Uma Menon, Meghan Kenner & Roger E Kelley. (2007) Perioperative stroke. Expert Review of Neurotherapeutics 7:8, pages 1003-1011.
Read now
Read now
Articles from other publishers (20)
Armin Sebastian Guntner, Bernhard Thalhamer, Christian Klampfl & Wolfgang Buchberger. (2019) Collision cross sections obtained with ion mobility mass spectrometry as new descriptor to predict blood-brain barrier permeation by drugs. Scientific Reports 9:1.
Crossref
Crossref
Weijing Qi, Lina Yan, Yaling Liu, Xiaomeng Zhou, Rui Li, Yafei Wang, Lin Bai, Juan Chen & Xiangyu Nie. (2019) Simvastatin aggravates impaired autophagic flux in NSC34-hSOD1G93A cells through inhibition of geranylgeranyl pyrophosphate synthesis. Neuroscience 409, pages 130-141.
Crossref
Crossref
Seok-Ho Lee, Na-Young Choi, Hyun-Jeung Yu, Jinse Park, Hojin Choi, Kyu-Yong Lee, Yong-Min Huh, Young Joo Lee & Seong-Ho Koh. (2015) Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging. Molecular Neurobiology 53:1, pages 695-705.
Crossref
Crossref
Wu-Fu Chung, Shih-Wei Liu, Peng-Yuan Chang, Feng-Shu Lin, Li-Fu Chen, Jau-Ching Wu, Yu-Chun Chen, Laura Liu, Wen-Cheng Huang, Henrich Cheng & Su-Shun Lo. (2015) Hyperlipidemia and Statins Affect Neurological Outcome in Lumbar Spine Injury. International Journal of Environmental Research and Public Health 12:1, pages 402-413.
Crossref
Crossref
Joy Derwenskus & Fred D. Lublin. 2014. Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders
563
577
.
Ryuichi Morishita & Hironori NakagamiMunehisa ShimamuraHironori NakagamiHitomi KurinamiNaoyuki SatoRyuichi Morishita. 2013. Gene Therapy: Technologies & Applications. Gene Therapy: Technologies & Applications
46
56
.
Arthur R. Menezes, Carl J. Lavie, Richard V. Milani & James O'Keefe. (2012) The Effects of Statins on Prevention of Stroke and Dementia. Journal of Cardiopulmonary Rehabilitation and Prevention 32:5, pages 240-249.
Crossref
Crossref
Zohara Sternberg, Alison Drake, Daniel S. Sternberg, Ralph H. B. Benedict, Fan Li, David Hojnacki, Bianca Weinstock-Guttmann & Frederick E. Munschauer. (2012) Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis. Journal of Clinical Immunology 32:3, pages 497-504.
Crossref
Crossref
Johann Sellner, Martin S. Weber, Patrick Vollmar, Heinrich P. Mattle, Bernhard Hemmer & Olaf Stüve. (2010) The Combination of Interferon‐Beta and HMG‐CoA Reductase Inhibition in Multiple Sclerosis: Enthusiasm Lost too Soon?. CNS Neuroscience & Therapeutics 16:6, pages 362-373.
Crossref
Crossref
Mansoureh Togha, Sanaz Ahmadi KarvighMasoud Nabavi, Nahid Beladi Moghadam, Mohammad Hossein Harirchian, Mohammad Ali Sahraian, Anahita Enzevaei, Alireza Nourian, Hossein Ghanaati, Kavous Firouznia, Ali Jannati & Majid Shekiba. (2010) Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial. Multiple Sclerosis Journal 16:7, pages 848-854.
Crossref
Crossref
W. Gibson Wood, Gunter P. Eckert, Urule Igbavboa & Walter E. Müller. (2010) Statins and neuroprotection. Annals of the New York Academy of Sciences 1199:1, pages 69-76.
Crossref
Crossref
Tammy A. Butterick, Urule Igbavboa, Gunter P. Eckert, Grace Y. Sun, Gary A. Weisman, Walter E. Müller & W. Gibson Wood. (2010) Simvastatin Stimulates Production of the Antiapoptotic Protein Bcl-2 via Endothelin-1 and NFATc3 in SH-SY5Y Cells. Molecular Neurobiology 41:2-3, pages 384-391.
Crossref
Crossref
Soeren A. PetersRudolf KleyMartin TegenthoffMatthias VorgerdVolkmar NicolasChristoph M. Heyer. (2010) MRI in Lipid-Lowering Agent–Associated Myopathy: A Retrospective Review of 21 Cases. American Journal of Roentgenology 194:4, pages W323-W328.
Crossref
Crossref
Anneke Van der Walt, Helmut Butzkueven, Scott Kolbe, Mark Marriott, Estella Alexandrou, Melissa Gresle, Gary Egan & Trevor Kilpatrick. (2010) Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade. Pharmacology & Therapeutics 126:1, pages 82-93.
Crossref
Crossref
Javier Barrios-González & Roxana U. Miranda. (2009) Biotechnological production and applications of statins. Applied Microbiology and Biotechnology 85:4, pages 869-883.
Crossref
Crossref
Zhao Yin, Yannan Fang, Li Ren, Xiaojuan Wang, Aiwu Zhang, Jianwen Lin & Xianliang Li. (2009) Atorvastatin attenuates NF-κB activation in trigeminal nucleus caudalis in a rat model of migraine. Neuroscience Letters 465:1, pages 61-65.
Crossref
Crossref
Benjamin M. Greenberg, John N. Ratchford & Peter A. Calabresi. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
685
702
.
A. Elsais, C. Lund & E. Kerty. (2008) Ptosis, diplopia and statins: an association?. European Journal of Neurology 15:10, pages e92-e93.
Crossref
Crossref
Johann Sellner, Isabell Greeve, Oliver Findling, Christian P. Kamm, Carsten Minten, Britta Engelhardt, Denis Grandgirard, Stephen L. Leib & Heinrich P. Mattle. (2008) Effect of interferon-β and atorvastatin on Th1/Th2 cytokines in multiple sclerosis. Neurochemistry International 53:1-2, pages 17-21.
Crossref
Crossref
J Sellner, I Greeve, O Findling, D Grandgirard, S L Leib & H P Mattle. (2008) Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. Clinical and Experimental Immunology 152:2, pages 280-284.
Crossref
Crossref